This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

13 Mar 2019

Third Sartorius Research Xchange Forum 2019 focuses on CAR-T cell therapy

Event for experts from academia and industry, including talks, live demo sessions, and panel discussion.

Promoting interdisciplinary exchange and fostering potential collaborations between academia and industry on highly promising scientific fields relevant to both scientists and businesses is the objective of Sartorius in hosting its third Research Xchange Forum (RXF2019) on 25 April 2019, which will spotlight CAR-T cell therapy.

The forum is being organized in collaboration with Science/AAAS. The American Association for the Advancement of Science (AAAS) is the world’s largest general scientific society, and the forum will be held at the AAAS headquarters in Washington DC. Experts from the academic, clinical and biotech sectors will offer insights on novel developments in CAR-T cell therapies.

Guest speakers will include Prof. Bruce Levine (University of Pennsylvania), Rick Morgan, Sr. VP Immunogenetics (Editas Medicine), and others from institutions such as UCLA, Boston University, MD Anderson Cancer Center, Horizon Discovery, Colorado State University, MaSTherCell and St Jude Children's Research Hospital.

The Sartorius & Science Prize for Regenerative Medicine & Cell Therapy will be awarded in an invitation-only post-event ceremony. Sartorius and Science/AAAS aim to recognize outstanding research contributions made in the regenerative medicine and cell therapy fields by the next generation of young scientists, the next thought leaders shaping our future as a society.

Mentioned Companies
Sartorius Stedim Biotech
View company profile

Related News